Usefulness of TAS-102 as Third-line Chemotherapy for Metastatic Colorectal Cancer

被引：0
|
作者：
Kawahara, Hidejiro [1 ]
Yanaga, Katsuhiko [1 ]
机构：
[1] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1448
引用
收藏
页码：601 / 601
页数：1
相关论文
共 50 条
  • [31] Review on TAS-102 development and its use for metastatic colorectal cancer
    Mota, Jose Mauricio
    Fonseca, Leonardo G.
    Braghiroli, Maria Ignez
    Hoff, Paulo M.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 104 : 91 - 97
  • [32] A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
    Chen, Xiaochen
    Qiu, Huafeng
    Chen, Yunwang
    Wang, Mingxing
    Zhu, Pengfei
    Pan, Shuangyue
    Deng, Yaya
    Yang, Liu
    Chen, Zheling
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer
    Jalali, A.
    Gard, G.
    Banks, S.
    Dunn, C.
    Wong, H. L.
    Wong, R.
    Lee, M.
    Gately, L.
    Loft, M.
    Shapiro, J. D.
    Kosmider, S.
    Tie, J.
    Ananda, S.
    Yeung, J. M.
    Jennens, R.
    Lee, B.
    McKendrick, J.
    Lim, L.
    Khattak, A.
    Gibbs, P.
    [J]. CURRENT PROBLEMS IN CANCER, 2022, 46 (02)
  • [34] Sidedness of the primary tumor on the effect of TAS-102 for refractory metastatic colorectal cancer
    Ueda, S.
    Tsuboguchi, Y.
    Nakatani, Y.
    Tsuya, A.
    Nishina, S-I.
    Akiyoshi, K.
    Okazaki, S.
    Tokunaga, S.
    Daga, H.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [35] Is there a third-line therapy for metastatic colorectal cancer?
    Grothey, Axel
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (06) : S36 - S38
  • [36] Third-Line Therapy in Metastatic Colorectal Cancer
    van de Haar, Joris
    Valeri, Nicola
    Voest, Emile E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (02): : 190 - 191
  • [37] Third-line therapy for metastatic colorectal cancer
    M. G. Gundgaard
    J. B. Soerensen
    E. Ehrnrooth
    [J]. Cancer Chemotherapy and Pharmacology, 2008, 61 : 1 - 13
  • [38] Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study
    Conti, Matteo
    Bolzacchini, Elena
    Luchena, Giovanna
    Bertu', Lorenza
    Tagliabue, Paola
    Aglione, Stefania
    Ardizzoia, Antonio
    Arnoffi, Jessica
    Guida, Francesco Maria
    Bertolini, Alessandro
    Pastorini, Alessandro
    Duro, Maria
    Bettega, Donato
    Roda', Giovambattista
    Artale, Salvatore
    Squizzato, Alessandro
    Giordano, Monica
    [J]. CANCERS, 2023, 15 (13)
  • [39] Neutropenia as a predictive factor in patients with metastatic colorectal cancer treated with TAS-102
    Hamauchi, S.
    Yamazaki, K.
    Masuishi, T.
    Kito, Y.
    Komori, A.
    Tsushima, T.
    Todaka, A.
    Yokota, T.
    Machida, N.
    Fukutomi, A.
    Onozawa, Y.
    Muro, K.
    Yasui, H.
    Mori, K.
    Taniguchi, H.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 50 - 51
  • [40] Effectiveness of TAS-102 in patients with metastatic colorectal cancer in a single comprehensive cancer center
    Sales, C.
    Juliao, I.
    Rosinha, A.
    Marques, D.
    Carneiro, F.
    Faustino, C.
    Machado, M.
    Ferreira, P.
    Fragoso, M.
    Sousa, N.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 79 - 79
12345